Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$263K Buy
816
+4
+0.5% +$1.31K 0.13% 84
2024
Q2
$254K Buy
812
+7
+0.9% +$2.06K 0.13% 86
2024
Q1
$229K Sell
805
-143
-15% -$41.8K 0.11% 95
2023
Q4
$273K Sell
948
-99
-9% -$27K 0.14% 92
2023
Q3
$281K Buy
+1,047
New +$261K 0.1% 123
2021
Q1
Sell
-924
Closed -$213K 75
2020
Q4
$213K Buy
+924
New +$213K 0.1% 76

Other funds holding AMGN

Bridge Advisory's AMGN Position: Q3 2024 in Review

Bridge Advisory increased its Amgen (AMGN) stake by 0.49% in Q3 2024, buying an estimated $1.31K and bringing the position to 816 shares worth $263K. The position accounts for 0.13% of the portfolio, ranked #84.

Bridge Advisory first reported a position in AMGN in Q4 2020 and has held it in 6 quarters since. The position peaked at $281K in Q3 2023. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Bridge Advisory held 816 shares of Amgen worth $263K as of Q3 2024.
  • Bridge Advisory bought 4 Amgen shares in Q3 2024, an estimated $1.31K.
  • Amgen made up 0.13% of Bridge Advisory's portfolio in Q3 2024, its #84 holding.
  • Bridge Advisory first reported a position in Amgen in Q4 2020 and has held it in 6 quarters since.
  • Bridge Advisory's Amgen position peaked at $281K in Q3 2023.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Bridge Advisory's 13F filing for Q3 2024, filed 1 Oct 2024.